))
S1 Ep52: JAK Inhibitor Safety for Treating AD
Manage episode 389992464 series 3538631
Contenuto fornito da The Cutaneous Connection. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da The Cutaneous Connection o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
In this episode, Christopher Bunick, MD, PhD, associate professor of dermatology at the Yale School Medicine, and a Dermatology Times Editorial Advisory Board member, discusses a paper he recently co-authored, titled “JAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies,” with Stefano Daniele, PhD candidate of the Medical Scientist Training Program at the Yale School of Medicine.
71 episodi
Condividi
